comprehensive -WSS

comprehensive

author：leisure time 2025-09-04 04:29:13 - browse：9893

Smartphone & medicine illustration — Alex Hogan/STAT

Pear Therapeutics may be gone, but one of its most important deals is still driving critical conversations about how medical apps can find a foothold in the slow-moving health care system.

In recent months, representatives of the Massachusetts state Medicaid program, MassHealth, have been presenting data suggesting reSET and reSET-O, Pear’s prescription apps that treat substance use disorder and opioid use disorder, saved the state money over a one-year period from 2021 to 2022. The data, which take into account health care utilization before and after people used the apps, have been presented to policymakers considering how to cover novel digital health products and shown to lawmakers considering federal legislation that would require Medicare coverage for prescription apps.

Pear, which filed for bankruptcy earlier this year, was one of the leading companies marketing prescription digital therapeutics, or Food and Drug Administration-cleared apps designed to treat disease. Pear’s reSET was the first such app cleared by the FDA in 2017.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： U.K. researchers warn about biases in medical devices, algorithms

WSS

Intermittent fasting comes with a heart risk? Not so fast

Lessons Learned: This is why you network to find that industry job you want

Plastic surgeons increase patient psychiatric screenings

NYC struggling to keep up with demand of supporting asylum seekers, Mayor Adams says

U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

AstraZeneca to buy developer of next

focus

comprehensive

leisure time

ChatGPT in medicine: STAT answers readers' burning questions

Judge rejects Trump's counterclaim against E. Jean Carroll

Hollywood unions extend contract negotiations for actors

Trump attorney outlines possible Jan. 6 legal defenses, but some experts are skeptical

Malaria cases in Florida and Texas: Here’s what you need to know

Judge rejects Trump's counterclaim against E. Jean Carroll

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Virtual Event: March of the Biosimilars

Bright Health sells Medicare Advantage business to Molina

Positive childhood experiences can help future health

entertainment

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

Leading voice in opioid treatment defends methadone clinic system

Asbestos, a deadly carcinogen, banned by EPA

Gene editing the human germline: What are the risks?

U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

Germany receives 178 compensation applications from gay servicepeople over discrimination

leisure time

focus

hotspot

Wikipedia